ORIGIN results on Lantus® cardiovascular safety integrated into European Union product label
5 June 2013 | By Sanofi
ORIGIN was a landmark, seven-year clinical trial...
List view / Grid view
News
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
5 June 2013 | By Novartis
Gilenya improved the key measures...
U.S. FDA grants priority review for Metreleptin
4 June 2013 | By Bristol-Myers Squibb Company
Metreleptin, an investigational agent for treatment of metabolic disorders associated with rare forms of LD...
Two real-world European studies of Abbott’s minimally invasive MitraClip® device demonstrate positive outcomes for patients with MR
4 June 2013 | By Abbott
Publication of positive outcomes...
AstraZeneca announces top-line results from Phase III OSKIRA Trials of FOSTAMATINIB
4 June 2013 | By AstraZeneca
AstraZeneca announced top-line results from OSKIRA-2 and OSKIRA-3...
Teva’s Lonquex® (XM22 lipegfilgrastim) recommended for approval in the EU
3 June 2013 | By Teva Pharmaceutical Industries Ltd
Teva’s Lonquex® (XM22 lipegfilgrastim) recommended for approval in the EU for the reduction of CIN...
Sanofi provides update on Phase 3 studies of two investigational compounds
3 June 2013 | By Sanofi
Sanofi announced topline results of two Phase 3 clinical studies...
AstraZeneca enters agreement with Hanmi Pharmaceuticals and Amneal Pharmaceuticals in US NEXIUM patent litigation
3 June 2013 | By AstraZeneca
AstraZeneca enters new agreement...
LUME-Lung 1: Nintedanib* plus chemotherapy extends the life of lung cancer patients with adenocarcinoma
3 June 2013 | By Boehringer Ingelheim
LUME-Lung 1 results represent the first advance in almost a decade...
GSK announces Phase III data for TYKERB/TYVERB® (lapatinib) in combination with chemotherapy for advanced HER2-positive gastric cancer
3 June 2013 | By GlaxoSmithKline
Study did not meet the primary endpoint...
Novartis breakthrough therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
3 June 2013 | By Novartis
Novartis announced data on its investigational compound LDK378...
Abbott previews next-generation blood screening prototype during International Society of Blood Transfusion Meeting
3 June 2013 | By Abbott
New solution underscores Abbott’s continued commitment to ensuring the safety of the blood supply...
Merck announces presentation of interim data from study evaluating Lambrolizumab
2 June 2013 | By Merck
Merck expands Lambrolizumab clinical development program...
Roche’s medicine Avastin plus chemotherapy improved survival in women with advanced cervical cancer, compared to chemotherapy alone
2 June 2013 | By Roche
Results of study GOG240...
Novartis pivotal Phase III trial shows Afinitor® significantly delays tumor growth in HER2 positive advanced breast cancer
2 June 2013 | By Novartis
Results from a pivotal Phase III trial...
